A Publicly Listed Pharmaceutical Group with Strong Industrial Foundation

2026-02-25 19:50:37

A Publicly Listed Pharmaceutical Group with Strong Industrial Foundation

China Dongcheng Pharmaceutical Group has established a solid industrial foundation backed by more than 20 years of experience in pharmaceutical manufacturing and innovation.

Since its listing on the Shenzhen Stock Exchange (Stock Code: 002675), the Group has continued to strengthen its capital structure, operational management, and global expansion strategy. As a publicly listed enterprise, Dongcheng adheres to high standards of governance, financial transparency, and compliance management.

Integrated Industrial Chain

Dongcheng has built an integrated pharmaceutical value chain covering:

• Raw material sourcing

• Biochemical extraction and purification

• API manufacturing

• Quality control and analytical testing

• Domestic and international commercialization

This vertically integrated structure ensures greater stability in supply, cost efficiency, and long-term sustainability.

Scalable Production Capacity

With modern production facilities and advanced manufacturing systems, the Group is capable of meeting growing global demand while maintaining consistent quality standards. Our scalable production capabilities support both large-volume contracts and long-term strategic cooperation.

Through industrial upgrading and continuous investment, Dongcheng strengthens its position as a competitive pharmaceutical API manufacturer in the global market.